Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma

Introduction: The effect of the conventional treatment methods of glioblastoma (GBM) is poor and the prognosis of patients is poor. The expression of MCL-1 in GBM is significantly increased, which shows a high application value in targeted therapy. In this study, we predicted the prognosis of gliobl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ao, Guo, Zhen, Ren, Jia-xin, Chen, Hongyu, Yang, Wenzhuo, Zhou, Yang, Pan, Lin, Chen, Zhuopeng, Ren, Fei, Chen, Youqi, Zhang, Menghan, Peng, Fei, Chen, Wanting, Wang, Xinhui, Zhang, Zhiyun, Wu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394558/
https://www.ncbi.nlm.nih.gov/pubmed/37538176
http://dx.doi.org/10.3389/fphar.2023.1162540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394558/
https://www.ncbi.nlm.nih.gov/pubmed/37538176
http://dx.doi.org/10.3389/fphar.2023.1162540

Ejemplares similares